▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2454 by analyst upside · 2026-09-27
CARL
Carlsmed, Inc.
Healthcare · Market Cap $412M · P/E 0x
ANALYST PRICE TARGET
+27.2%
implied upside to consensus target
Current Price $15.1
Consensus Target $19.2
Bull Target $23.0
Bear Target $17.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
3
Hold
0
Sell
0
52-Week Low $8.5
52-Week High $17.23
YTD Return +29.8%
FUNDAMENTALS
Market Cap $412M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-2.34
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $63M
Profit Margin -57.4%
52-WEEK RANGE
52-Week Low $8.5
52-Week High $17.23
Current Price $15.1
Bear Target $17.0
Bull Target $23.0
● Now $15.1 ● Target $19.2
TRADING DATA
Avg Volume 137K
YTD Return +29.8%
Analyst Count 5
Consensus Buy
Upside to Target +27.2%
Last Updated 2026-09-27

ANALYST SUMMARY

Carlsmed, Inc. (CARL) is currently trading at $15.1 with a Wall Street consensus price target of $19.2, implying potential upside of 27.2% over the next 12 months. 5 analysts currently cover CARL, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $23.0, while the most cautious has a target of $17.0.

CARL operates in the Healthcare sector with a market capitalisation of $412M. The stock is up 29.8% year-to-date and is currently trading near the upper end of its 52-week range of $8.5 – $17.23.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CYH +7.4%
Community Health Systems, Inc.
$415M · P/E 1.7x · Hold
EMBC -32.2%
Embecta Corp.
$334M · P/E 4.0x · Hold
VMD +40.3%
Viemed Healthcare, Inc.
$339M · P/E 24.7x · Buy
KMDA +54.8%
Kamada Ltd.
$503M · P/E 22.9x · Buy
TCMD +71.6%
Tactile Systems Technology, Inc.
$515M · P/E 20.9x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for CARL, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Truist Securities - Reiterated
Buy → Buy 2026-08-06 Building track record
Needham ● Initiated
Buy 2026-07-01 20% win rate (5 calls)
BTIG reit
Buy → Buy 2026-05-06 38% win rate (8 calls)
Truist Securities - Reiterated
Buy → Buy 2026-04-15 Building track record
Goldman Sachs - Reiterated
Buy → Buy 2026-04-09 Building track record
BTIG reit
Buy → Buy 2025-12-15 38% win rate (8 calls)
Truist Securities reit
Buy → Buy 2025-11-07 Building track record
BTIG - Reiterated
Buy → Buy 2025-11-07 38% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
63
out of 100
Coverage depth
14/30
Consensus clarity
22/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →